Amantadine in Treating Cognitive & Motor Impairments in Adolescents and Adults With Cerebral Palsy

• Status: Recruiting
• Trial end date: 2023-09-01
• Target enrollment: 0
• Participant gender: All

Summary

Cerebral palsy (CP) is a common childhood-onset disability associated with motor and cognitive impairments, however most research is focused on motor outcomes. The aim of this study is to determine the effects of Amantadine, a dopaminergic agonist, on cognitive function in adolescents and adults with CP.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Columbia University
• Treatments: Amantadine

Criteria

Inclusion Criteria:

• Diagnosed with Cerebral Palsy

Exclusion Criteria:

• Currently pregnant

• Unstable seizure condition

• Currently taking methadone

• Currently taking other dopamine agonists

• Currently taking anti-psychotic medication

• Previously taken amantadine

• Diagnosed with Chronic Kidney Disease (CKD)